Condition: Transplant; Failure, Heart · Hepatitis C · Sponsor: Baylor Research Institute
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
This description comes directly from the study's public registry record.
Joost Felius, PhD · 214-818-8943 · Joost.Felius@BSWHEALTH.ORG
Always discuss trial participation with your own doctor first.
| Baylor Scott & White Health Research Institute | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04493385